*  A Multicenter, Open Label, 2 Period Cross-Over Study to Evaluate the PK of a 8 Week Continuous Treatment With 1x300mg/d and...
... safety and tolerability of two continuous treatment regimes of tobramycin nebulized ... 2 Period Cross-Over Study to Evaluate the PK of a 8 Week Continuous Treatment With 1x300mg/d and 2x300mg/d Tobramycin Inhaled ... 2 Period Cross-Over Study to Evaluate the PK of a 8 Week Continuous Treatment With 1x300mg/d and 2x300mg/d Tobramycin Inhaled ...
http://adisinsight.springer.com/trials/700032091?error=cookies_not_supported&code=15ddd1b9-3f08-413b-b100-1bed718bb83d